ROS-Responsive Hydrogel Delivering METRNL Enhances Bone Regeneration via Dual Stem Cell Homing and Vasculogenesis
Yue Xu1, Rui Huang1, Wodong Shi1
1State Key Laboratory of Eye Health, Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, China.
Advanced Healthcare Materials
|May 20, 2025
Summary
This study developed a novel ROS-scavenging hydrogel that delivers METRNL to repair critical-sized bone defects. The system modulates the bone microenvironment, promoting stem cell homing and new blood vessel growth for accelerated bone regeneration.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Critical-sized bone defects impede natural healing due to a hostile microenvironment.
- This microenvironment is characterized by excessive reactive oxygen species (ROS), vascular damage, and insufficient osteoblasts.
- Restoring microenvironmental balance is crucial for effective bone repair.
Purpose of the Study:
- To develop a ROS-responsive hydrogel system for targeted delivery of METRNL to modulate the bone microenvironment.
- To investigate the potential of this system in promoting bone regeneration by enhancing stem cell recruitment and angiogenesis.
- To evaluate the therapeutic efficacy in a rat cranial bone defect model.
Main Methods:
- Development of a ROS-cleavable GelMA-based hydrogel (RRG-MRL) loaded with METRNL.
- In vitro assessment of ROS scavenging, METRNL release kinetics, and cellular responses (angiogenesis, stem cell recruitment).
- In vivo evaluation in a rat cranial bone defect model, assessing ROS levels, cell infiltration, neovascularization, and bone regeneration.
Main Results:
- The RRG-MRL hydrogel effectively scavenged ROS and released METRNL in response to oxidative stress.
- METRNL promoted endothelial cell angiogenesis via the c-Kit/PI3K/Akt pathway and enhanced bone marrow mesenchymal stem cell (BMSC) recruitment.
- In vivo studies showed reduced ROS, increased BMSCs, enhanced vascularization, and accelerated bone regeneration in treated defects.
Conclusions:
- The ROS-responsive METRNL-delivering hydrogel acts as a bone microenvironment-modulating system.
- This platform facilitates bone regeneration by restoring homeostasis, promoting cell homing, and enhancing angiogenesis.
- The developed system shows significant potential for clinical application in treating critical-sized bone defects.


